Buchumschlag

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Richard B. Lipton, Jonathan Stokes, Christopher J. Evans, Elizabeth Hribal, Kailee White, Katelyn Keyloun, Krutika Parikh, Pranav Gandhi, David W. Dodick
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Headache: The Journal of Head and Face Pain
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
von: Richard B. Lipton, et al.
Veröffentlicht: (2025)

Integrating gepants into clinical practice for the acute treatment of migraine
von: Richard B. Lipton, et al.
Veröffentlicht: (2026)

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
von: Stephen D. Silberstein, et al.
Veröffentlicht: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
von: Rikki Mangrum, et al.
Veröffentlicht: (2024)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
von: Lawrence C. Newman, et al.
Veröffentlicht: (2025)

Hemicrania continua exacerbations with prodromal burping as a potential autonomic symptom
von: Raluca A. Negulescu, et al.
Veröffentlicht: (2026)

Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy ( MOTS ) trial
von: Samantha C. Shao, et al.
Veröffentlicht: (2024)

Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study
von: Dawn C. Buse, et al.
Veröffentlicht: (2024)

Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program
von: Idris Demirsoy, et al.
Veröffentlicht: (2025)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
von: Bilal Ahmed Rizvi, et al.
Veröffentlicht: (2024)

Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
von: Antonio Munafò, et al.
Veröffentlicht: (2026)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
von: David Kudrow, et al.
Veröffentlicht: (2025)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
von: Susan Hutchinson, et al.
Veröffentlicht: (2026)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
von: Jessica Ailani, et al.
Veröffentlicht: (2024)

Prevalence and burden of migraine in the United States: A systematic review
von: Fred Cohen, et al.
Veröffentlicht: (2024)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
von: Jessica Ailani, et al.
Veröffentlicht: (2026)

Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study
von: David W. Dodick, et al.
Veröffentlicht: (2025)

Cognitive symptoms in veterans with migraine or traumatic brain injury: A Million Veteran Program study
von: Matthew S. Herbert, et al.
Veröffentlicht: (2024)

Comparative analysis of real‐world acute prescription migraine therapy outcomes: Insights from the HeAD – US study
von: Devin Teichrow, et al.
Veröffentlicht: (2026)

Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society
von: Todd J. Schwedt, et al.
Veröffentlicht: (2025)

What a long strange trip it's been: Reflections on serial snapshots of migraine prevalence and burden in the United States
von: Fred Cohen, et al.
Veröffentlicht: (2025)

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study
von: Gabriel Paiva da Silva Lima, et al.
Veröffentlicht: (2025)

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
von: Muneto Tatsumoto, et al.
Veröffentlicht: (2024)

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study
von: Richard B. Lipton, et al.
Veröffentlicht: (2025)

Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings
von: Fred Cohen, et al.
Veröffentlicht: (2024)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
von: Graham A. McLeod, et al.
Veröffentlicht: (2025)

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study
von: Dawn C. Buse, et al.
Veröffentlicht: (2025)

A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine ( TEAM) study
von: Gregory A. Panza, et al.
Veröffentlicht: (2024)

Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment
von: Joanna K. Bougie, et al.
Veröffentlicht: (2024)

Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi‐source dataset, observational cohort study
von: Dawn C. Buse, et al.
Veröffentlicht: (2026)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
von: Yunus Emre Meydanal, et al.
Veröffentlicht: (2025)

Evaluating associations of migraine‐related vertigo
von: Nazia Karsan, et al.
Veröffentlicht: (2025)

Preserved working memory performance along with subcortical modulation during peri‐ictal phases in spontaneous migraine attacks
von: Amparo Ruiz‐Tagle, et al.
Veröffentlicht: (2024)

Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study
von: Maggie R. Mittleman, et al.
Veröffentlicht: (2024)

Afterimage duration differs for migraine with or without aura
von: Florian Rimmele, et al.
Veröffentlicht: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
von: Rebecca Erwin Wells, et al.
Veröffentlicht: (2024)

Useful considerations for treating migraine in patients with autism
von: Sinifunanya E. Nwaobi
Veröffentlicht: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
von: Gabriel Camargo de Oliveira, et al.
Veröffentlicht: (2026)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
von: Shuu‐Jiun Wang, et al.
Veröffentlicht: (2024)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
von: Inga Zalia Tummoszeit, et al.
Veröffentlicht: (2024)